Z-Medica Corp Launches First Two Rapid Blood Clotting Products for Consumers - Including First Antimicrobial Formulation

WALLINGFORD, Conn., July 17 /PRNewswire/ -- Z-Medica Corporation (Z-Medica), a medical products company focused on innovative blood clotting nano-technologies, has launched its first two rapid blood clotting products for consumers, following the...


WALLINGFORD, Conn., July 17 /PRNewswire/ -- Z-Medica Corporation (Z-Medica), a medical products company focused on innovative blood clotting nano-technologies, has launched its first two rapid blood clotting products for consumers, following the success of its products for the military, first responder and security markets. QuikClot Sport(TM) and QuikClot Sport Silver(TM) -- the first QuikClot(R) brand hemostat formulation with antimicrobial properties -- were created with the general sports and adventure enthusiast in mind, particularly those whose sports and outdoor activities carry the possibility of a bleeding injury far from professional medical attention. The new products have received 510k clearance from the U.S. Food & Drug Administration (FDA) and are available over the counter.

The products rapidly stop even severe bleeding safely and effectively following simple package directions. Designed to fit easily into backpacks and first aid kits, QuikClot Sport(TM) and QuikClot Sport Silver(TM) come in 25gram and 50gram 'clotting sponges' that are packed into the wound. The potentially lifesaving sponges retail for as low as $9.99. The products will be available at retail stores and through catalogues this spring including at http://www.cabelas.com. For further information, visit http://www.z-medica.com/sportinfo.

In developing the QuikClot(R) consumer products, Z-Medica's in-house product development team collaborated with Galen Stucky , a professor of chemistry and biochemistry at the University of California, Santa Barbara and with the United States Navy, which provided support for Stucky's research through the Office of Naval Research (ONR) and product testing at the Naval Medical Research Center.

"As we have transitioned our products from the military market to the first responder market, it has been an important goal of our company to next get the lifesaving capabilities of QuikClot(R) into the hands of consumers," said Huey. "Targeting our first consumer products to the outdoor adventure and sports markets was in response to countless inquiries from hunting, fishing, skiing, boating, cycling and other sporting organizations."

QuikClot(R) has saved scores of lives on the battlefields of Iraq and Afghanistan . First responders, safety and security organizations across the United States are also saving lives using various QuikClot product versions. It is the most widely used hemostatic first aid product available with more than one million units deployed worldwide.

QuikClot consumer product development accelerated when Z-Medica and its research partners worked to re-engineer the original formulation, eliminating its potential to generate heat with improper use. Dr. Galen Stucky 's team also created a QuikClot formulation with silver ions that provides antimicrobial properties in addition to effective clotting. His contribution to understanding the mechanisms of action of the clotting process represents a significant scientific advance.

QuikClot Sport(TM) and QuikClot Sport Silver(TM) consist of beads of QuikClot(R) enclosed in a porous surgical fabric, similar to the latest products for the military and first responders. When introduced into a wound, this sponge takes the shape of the injury and rapidly stops even severe venous and arterial bleeding. The sponge stays in place until easily removed in the hospital. QuikClot represents the first and most effective solution to severe blood loss outside the operating room setting.

Z-Medica headquarters is located at 4 Fairfield Blvd., Wallingford, Connecticut 06492. For more information, please call (203) 294.0000 or visit http://www.z-medica.com.

SOURCE Z-Medica Corporation